WallStSmart
KRRO

Frequency Therapeutics Inc

NASDAQ: KRRO · HEALTHCARE · BIOTECHNOLOGY

$13.49
+6.98% today

Updated 2026-04-30

Market cap
$196.07M
P/E ratio
—
P/S ratio
30.68x
EPS (TTM)
$-12.48
Dividend yield
—
52W range
$5 – $56
Volume
0.2M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Frequency Therapeutics Inc (KRRO) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item201720182019202020212022202320242025
Revenue——$28.95M$36.98M$14.07M$0.00$0.00$2.27M$6.39M
Revenue growth (YoY)———+27.8%-62.0%-100.0%——+181.5%
Cost of revenue$531000.00$654000.00$16.81M$1.58M$3.84M$2.51M$3.63M$3.56M$4.28M
Gross profit$-531000.00$-654000.00$12.13M$35.40M$10.23M$-2.51M$-3.63M$2.27M$2.11M
Gross margin——41.9%95.7%72.7%——100.0%33.0%
R&D$11.79M$11.58M$18.33M$36.66M$59.32M$42.20M$57.25M$63.64M$65.58M
SG&A————$11.69M$16.80M$24.03M$30.55M$28.16M
Operating income$-16.31M$-18.94M$-20.68M$-27.55M$-84.03M$-59.00M$-84.53M$-91.91M$-87.34M
Operating margin——-71.4%-74.5%-597.3%——-4047.1%-1366.4%
EBITDA$-19.53M$-18.41M$-17.93M$-24.90M$-80.07M$-56.49M$-80.90M$-88.34M$-83.06M
EBITDA margin——-62.0%-67.3%-569.1%——-3890.1%-1299.5%
EBIT$-20.06M$-19.06M$-18.75M$-26.48M$-83.91M$-59.00M$-84.53M$-91.91M$-87.34M
Interest expense$174000.00$106000.00——$764000.00$118000.00———
Income tax—————————
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-20.24M$-19.17M$-18.75M$-26.51M$-84.69M$-58.03M$-81.17M$-83.58M$-117.26M
Net income growth (YoY)—+5.3%+2.2%-41.4%-219.4%+31.5%-39.9%-3.0%-40.3%
Profit margin——-64.8%-71.7%-602.0%——-3680.4%-1834.5%